Sixteen lots of clonazepam orally disintegrating tablets have been recalled because of a packaging error that could have life ...

The company that produces the tablets has said the medication is mislabeled with the incorrect strength on the carton.

Endo USA, Inc., affiliated to generics and specialty branded pharmaceutical company Endo, Inc., has expanded its recall of Clonazepam ...

The company is worried mislabeling could lead to unintentionally taking higher doses and adverse side effects.

(RTTNews) - Endo USA, Inc., affiliated to generics and specialty branded pharmaceutical company Endo, Inc., has expanded its recall of Clonazepam Orally Disintegrating Tablets (C-IV), according to ...

Endo USA is expanding its previous recall of orally disintegrating clonazepam tablets to include more than a dozen additional product lots, the company said in a notice posted on the FDA’s ...

To date, Endo has not received any reports of adverse events associated with this product recall. Clonazepam Orally Disintegrating Tablets are indicated alone or as an adjunct in the treatment of ...

Nov. 18, 2024 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI) ("Endo") announced today that one of its operating subsidiaries, Endo USA, Inc., is expanding its previously announced voluntary recall of ...

Credit: Endo, Inc At this time, there have been no reports of adverse events related to this recall. While the blister strips within the cartons reflect the correct strength and lot number, the ...